Abstract
The effect of lyso-PAF on ciliated cells was investigated in vitro. Normal mucosa was surgically obtained from human paranasal sinuses and incubated in the form of tissue culture. Ciliated epithelium was magnified under an inverted microscope, and ciliary movement was photo-electrically measured. Ciliary activity was significantly inhibited by 10−8 M lyso-PAF and could be restored. The effect of lyso-PAF was completely blocked by CV-6209, a specific PAF antagonist. The PAF concentration in the incubation medium of lyso-PAF was determined by radioimmunoassay, because PAF is a well known inhibitor of ciliary activity. PAF gradually increased and after 20 min reached its maximal level. These findings indicated the existence of an enzyme in the paranasal sinus mucosa, by which lyso-PAF is converted to PAF, and that lyso-PAF can inhibit ciliary activity by means of PAF.
Full Text
The Full Text of this article is available as a PDF (337.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alonso F., Gil M. G., Sánchez-Crespo M., Mato J. M. Activation of 1-alkyl-2-lysoglycero-3-phosphocholine. Acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes. J Biol Chem. 1982 Apr 10;257(7):3376–3378. [PubMed] [Google Scholar]
- Blank M. L., Lee T., Fitzgerald V., Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem. 1981 Jan 10;256(1):175–178. [PubMed] [Google Scholar]
- Chung K. F., Aizawa H., Leikauf G. D., Ueki I. F., Evans T. W., Nadel J. A. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther. 1986 Mar;236(3):580–584. [PubMed] [Google Scholar]
- Cuss F. M., Dixon C. M., Barnes P. J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986 Jul 26;2(8500):189–192. doi: 10.1016/s0140-6736(86)92489-x. [DOI] [PubMed] [Google Scholar]
- Ganbo T., Hisamatsu K. Mucosal dysfunction and damage induced by platelet activating factor (PAF). Acta Otolaryngol. 1990 Nov-Dec;110(5-6):427–436. doi: 10.3109/00016489009107465. [DOI] [PubMed] [Google Scholar]
- Ganbo T., Hisamatsu K., Nakazawa T., Kamijo A., Murakami Y. Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro. Rhinology. 1991 Sep;29(3):231–237. [PubMed] [Google Scholar]
- Lee T. C., Malone B., Wasserman S. I., Fitzgerald V., Snyder F. Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem Biophys Res Commun. 1982 Apr 29;105(4):1303–1308. doi: 10.1016/0006-291x(82)90928-7. [DOI] [PubMed] [Google Scholar]
- Misawa M., Iwamura S. Platelet-activating factor (PAF)-induced rhinitis and involvement of PAF in allergic rhinitis in guinea pigs. Jpn J Pharmacol. 1990 Oct;54(2):217–226. doi: 10.1254/jjp.54.217. [DOI] [PubMed] [Google Scholar]
- Ninio E., Mencia-Huerta J. M., Heymans F., Benveniste J. Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. Biochim Biophys Acta. 1982 Jan 15;710(1):23–31. doi: 10.1016/0005-2760(82)90185-0. [DOI] [PubMed] [Google Scholar]
- Terashita Z., Imura Y., Takatani M., Tsushima S., Nishikawa K. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J Pharmacol Exp Ther. 1987 Jul;242(1):263–268. [PubMed] [Google Scholar]
- Wykle R. L., Malone B., Snyder F. Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. J Biol Chem. 1980 Nov 10;255(21):10256–10260. [PubMed] [Google Scholar]